Table 2.
Symptoms at enrollment and clinical outcomes for patients with RSV and HMPV
| Characteristic | RSV infection (n = 32) | HMPV infection (n = 33) | P value |
|---|---|---|---|
| Duration of symptoms in days, median (25%, 75%) | 4 (2, 6) | 3 (2, 4) | 0·670 |
| Symptoms/Signs, n (%) | |||
| Congestion/Rhinorrhea | 25 (78·1) | 24 (72·7) | 0·614 |
| Sore throat | 19 (59·4) | 13 (39·4) | 0·107 |
| Cough | 29 (90·6) | 32 (97) | 0·287 |
| Dyspnea | 30 (93·8) | 32 (97) | 0·536 |
| Wheezing | 29 (90·6) | 26 (78·8) | 0·186 |
| Earache | 11 (34·4) | 6 (18·2) | 0·137 |
| Fever | 19 (59·4) | 23 (69·7) | 0·461 |
| GI symptoms | 13 (40·6) | 18 (54·6) | 0·261 |
| Decreased appetite | 23 (71·9) | 25 (75·8) | 0·722 |
| Myalgias | 17 (53·1) | 19 (57·6) | 0·718 |
| Headache | 21 (65·6) | 19 (57·6) | 0·505 |
| Fatigue | 31 (96·9) | 27 (81·8) | 0·050 |
| Altered mental status | 7 (21·9) | 9 (27·3) | 0·614 |
| Clinical outcomes among those hospitalized N | N = 24 | N = 27 | |
| Length of stay in days, median (25%, 75%) | 4 (2, 5) | 3 (2, 4) | 0·877 |
| ICU admission, n (%) | 4 (16·7) | 2 (7·4) | 0·306 |
| Length of stay in ICU in days, median (25%, 75%) | 3 (2·5, 5·0) | 4·5 (1·0, 8·0) | 0·489 |
| Need for mechanical ventilation, n (%) | 1 (4·2) | 0 (0) | 0·284 |
| Death, n (%) | 1 (4·2) | 0 (0) | 0·284 |